ExoPTEN (NurExone Biologic)

N/A

Report date: 2026/01/28 17:44:38

Base Information

Drug NameExoPTEN (NurExone Biologic)

Drug Alias NameN/A

ClassificationBiologics > Exosomes > Stem cell-derived exosomesCell and gene therapy > Cell therapy > Stem cell therapySmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA

Mechanisms of ActionPhosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN inhibitorsNeuroprotectants

TargetsPhosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN

Therapy Area/IndicationsGlaucomaSpinal Cord Injuries

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsYes

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNurExone Biologic Inc

China Registration ClassN/A

Develop Information

Active CompaniesNurExone Biologic Inc

Inactive CompaniesN/A

Active IndicationsGlaucomaSpinal Cord Injuries

Inactive IndicationsN/A

Other Information

ATC CodeN/A